Stockreport

Lilly's next-gen obesity drug shows reduction in blood sugar levels in trial [Yahoo! Finance]

Novo Nordisk A/S  (NVO) 
Last novo nordisk a/s earnings: 2/5 01:31 am Check Earnings Report
US:NYSE Investor Relations: novonordisk.com/investors.html
PDF on ?Thursday, as it looks to widen its lead in the heavily ?contested market for GLP-1 drugs. Drug developers are racing to enter the highly competitive and booming ob [Read more]